Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
25.41
-0.02 (-0.08%)
Nov 21, 2024, 12:32 PM EST - Market open
Enliven Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 1,242 | 570 | - | - | - |
| Enterprise Value | 951 | 307 | - | - | - |
| Last Close Price | 25.43 | 13.84 | - | - | - |
| PB Ratio | 4.17 | 2.32 | - | - | - |
| P/TBV Ratio | 4.18 | 2.32 | - | - | - |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| Quick Ratio | 17.14 | 9.78 | 7.78 | 19.12 | 88.20 |
| Current Ratio | 17.44 | 10.28 | 8.00 | 19.24 | 88.35 |
| Return on Equity (ROE) | -30.98% | -44.90% | -41.90% | -20.94% | - |
| Return on Assets (ROA) | -21.37% | -28.94% | -24.66% | -12.67% | - |
| Return on Capital (ROIC) | -22.50% | -32.14% | -26.86% | -13.08% | - |
| Earnings Yield | -6.86% | -12.55% | - | - | - |
| FCF Yield | -5.52% | -10.77% | - | - | - |
| Buyback Yield / Dilution | -72.23% | -1037.74% | 60.02% | -56.70% | - |
| Total Shareholder Return | -72.23% | -1037.74% | 60.02% | -56.70% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.